Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07127757 · ClinicalTrials.gov registry record

Clinical Evaluation of WaveLight Plus LASIK

A clinical trial of Myopia and Astigmatism, sponsored by Laser Defined Vision.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT07127757 is a study of Myopia and Astigmatism that is actively recruiting participants, run by Laser Defined Vision. The registered enrollment target is 50 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07127757, a study of Myopia and Astigmatism, is actively recruiting participants, sponsored by Laser Defined Vision.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, and administration of the adapted PROWL and Low Luminance Questionnaire (LLQ-32) Questionnaire.

Conditions Studied

Interventions

  • DEVICE Wavelight Plus LASIK

Study Locations (1)

North Carolina

  • Laser Defined Vision - Greensboro

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-08-28
Est. Completion 2026-09-01

Sponsor

Laser Defined Vision

2 total trials

What the Registry Record Tells You About NCT07127757

The ClinicalTrials.gov registry entry for NCT07127757 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (81% lower). The listed sponsor is Laser Defined Vision, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Wavelight Plus LASIK is the first listed.

NCT07127757 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT07127757 about?

NCT07127757 is a clinical study titled "Clinical Evaluation of WaveLight Plus LASIK". This study is a single-site, single-arm, prospective, observational study of subject satisfaction, quality of vision, and quality of life after bilateral LASIK surgery. Subjects will be assessed up to 3 months post-operatively. Clinical evaluations will include refractive outcomes, visual acuity, an...

What is the current status of trial NCT07127757?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-08-28. Estimated completion is 2026-09-01.

What conditions does trial NCT07127757 study?

This clinical trial studies the following conditions: Myopia, Astigmatism.

What interventions are being tested in trial NCT07127757?

The interventions under investigation include: Wavelight Plus LASIK (DEVICE).

Who is sponsoring clinical trial NCT07127757?

This trial is sponsored by Laser Defined Vision, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07127757 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.